Blog
RSS FeedPosted by Michael Wonder on 13 Apr 2019
FDA approves first targeted therapy for metastatic bladder cancer
12 April 2019 - The U.S. FDA today granted accelerated approval to Balversa (erdafitinib), a treatment for adult patients with locally ...
Posted by Michael Wonder on 12 Apr 2019
FDA approves expanded monotherapy label for Merck’s Keytruda (pembrolizumab)
11 April 2019 - Keytruda now approved for first-line treatment of patients with Stage III NSCLC who are not candidates for ...
Posted by Michael Wonder on 11 Apr 2019
The perils of value based pricing for prescription drugs
11 April 2019 - How do you determine the value, and the price, of life-saving medication? ...
Posted by Michael Wonder on 11 Apr 2019
Institute for Clinical and Economic Review posts draft scoping document for the assessment of treatments for rheumatoid arthritis
11 April 2019 - Document open to public comment until 1 May 2019. ...
Posted by Michael Wonder on 11 Apr 2019
Institute for Clinical and Economic Review to assess treatments for type 2 diabetes mellitus
11 April 2019 - Report will be subject of New England CEPAC meeting in November 2019; open Input now being ...
Posted by Michael Wonder on 11 Apr 2019
On rising insulin prices, law maker tells pharma execs: 'Your days are numbered'
10 April 2019 - Lawmakers tensed with frustration, some clenching their jaws, while grilling a panel of pharmacy and pharmaceutical ...
Posted by Michael Wonder on 11 Apr 2019
Would ‘Medicare for all’ save billions or cost billions?
10 April 2019 - How much would a “Medicare for all” plan, like the kind being introduced by Senator Bernie ...
Posted by Michael Wonder on 11 Apr 2019
Cosmo Pharmaceuticals announces submission of remimazolam NDA TO FDA
9 April 2019 - Cosmo Pharmaceuticals today informed that the Remimazolam NDA has been submitted to FDA. ...
Posted by Michael Wonder on 10 Apr 2019
FDA, Brigham and Women’s to test if RWE is ripe now for replacing clinical drug trials
10 April 2019 - Can real-world evidence substitute for a clinical drug trial that meets the full gold standard on data? ...
Posted by Michael Wonder on 10 Apr 2019
Sanofi sets a fixed price of insulin at $99 per month for some patients
10 April 2019 - Sanofi says it will sell monthly supplies of insulin for a fixed price of $99 to patients ...
Posted by Michael Wonder on 10 Apr 2019
‘He calls me, I call him’: Alex Azar on his relationship with President Trump, drug pricing, and winning over skeptical conservatives
10 April 2019 - Alex Azar speaks about his efforts to lower drug prices multiple times each week with President ...
Posted by Michael Wonder on 10 Apr 2019
The biopharmaceutical cartel and high drug prices
10 April 2019 - Given the attacks on the biopharmaceutical industry by “pharmascolds”, one would think that all of the negative ...
Posted by Michael Wonder on 10 Apr 2019
CVS, Cigna, Humana blame big pharma at Senate hearing for skyrocketing US drug prices
9 April 2019 - In written testimony submitted to the Senate Finance Committee, they blasted the drug industry for the rising ...
Posted by Michael Wonder on 10 Apr 2019
The evolving uses of “real world” data
9 April 2019 - The terms real world data and real-world evidence have entered the medical lexicon to refer to ...
Posted by Michael Wonder on 10 Apr 2019
Sanders to roll out updated 'Medicare for all' proposal Wednesday
8 April 2019 - Senator Bernie Sanders will roll out an updated version of his "Medicare for all" plan Wednesday ...